These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24383130)

  • 1. Percutaneous comprehensive cryoablation for metastatic esophageal cancer after failure of radical surgery.
    Jiongyuan X; Lizhi N; Feng M; Shupeng L; Yin L; Mengtian L; Jianying Z; Fei Y; Jibing C; Jialiang L; Kecheng X
    Cryobiology; 2013 Dec; 67(3):363-8. PubMed ID: 24383130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryotherapy protocols for metastatic breast cancer after failure of radical surgery.
    Niu L; Mu F; Zhang C; Li Y; Liu W; Jiang F; Li L; Liu C; Zeng J; Yao F; Chen J; Li J; Zuo J; Xu K
    Cryobiology; 2013 Aug; 67(1):17-22. PubMed ID: 23619024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen as prognostic factor for metastatic non-small cell lung cancer by percutaneous cryosurgery.
    Li H; Tang K; Niu L; Liang Y; Li J; Chen J; Xu K
    Cancer Biomark; 2013; 13(5):337-43. PubMed ID: 24440973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer.
    Yuanying Y; Lizhi N; Feng M; Xiaohua W; Jianying Z; Fei Y; Feng J; Lihua H; Jibing C; Jialiang L; Kecheng X
    Cryobiology; 2013 Oct; 67(2):235-40. PubMed ID: 23948179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous comprehensive cryoablation for metastatic hepatocellular cancer.
    Mu F; Niu L; Li H; Liao M; Li L; Liu C; Chen J; Li J; Zuo J; Xu K
    Cryobiology; 2013 Feb; 66(1):76-80. PubMed ID: 23237910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer.
    Niu L; Chen J; He L; Liao M; Yuan Y; Zeng J; Li J; Zuo J; Xu K
    Pancreas; 2013 Oct; 42(7):1143-9. PubMed ID: 23899940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous cryotherapy for metastatic bladder cancer: experience with 23 patients.
    Liang Z; Fei Y; Lizhi N; Jianying Z; Zhikai Z; Jibing C; Jialiang L; Kecheng X
    Cryobiology; 2014 Feb; 68(1):79-83. PubMed ID: 24368268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-guided percutaneous cryoablation combined with systemic chemotherapy for liver metastases from esophageal carcinoma: Initial experience.
    Wang Y; Zhang WH; Chang X; Cao F; Yu HP; Xing WG; Yang XL; Guo Z
    Cryobiology; 2019 Apr; 87():99-104. PubMed ID: 30703348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer.
    Yoshii T; Ohkawa S; Tamai S; Kameda Y
    Dis Esophagus; 2013 Jul; 26(5):496-502. PubMed ID: 22676622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryotherapy for the prevention and treatment of esophageal cancer: when does efficacy equal success?
    Hernandez LV; Eisen GM
    Gastrointest Endosc; 2010 Apr; 71(4):694-6. PubMed ID: 20363411
    [No Abstract]   [Full Text] [Related]  

  • 11. Percutaneous cryoablation for stage IV lung cancer: a retrospective analysis.
    Niu L; Chen J; Yao F; Zhou L; Zhang C; Wen W; Bi X; Hu Y; Piao X; Jiang F; Zeng J; Liu W; Li J; He L; Mu F; Zuo J; Xu K
    Cryobiology; 2013 Oct; 67(2):151-5. PubMed ID: 23806858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients.
    Dumot JA; Vargo JJ; Falk GW; Frey L; Lopez R; Rice TW
    Gastrointest Endosc; 2009 Oct; 70(4):635-44. PubMed ID: 19559428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
    Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
    J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer.
    Niu LZ; Li JL; Zeng JY; Mu F; Liao MT; Yao F; Li L; Liu CY; Chen JB; Zuo JS; Xu KC
    World J Gastroenterol; 2013 Jun; 19(22):3473-80. PubMed ID: 23801841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Treatment Outcomes for Locally Advanced Esophageal Cancer: A Single-Institution Experience.
    Sio TT; Wilson ZC; Stauder MC; Bhatia S; Martenson JA; Quevedo JF; Schomas DA; Miller RC
    Am J Clin Oncol; 2016 Oct; 39(5):448-52. PubMed ID: 24879469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Esophageal cancer: outcome according to therapeutic strategy].
    Rousseau D; Capitain O; Denis F; Girault S; Poirier AL; Paumier A; Cellier P; Hamy A; Mahé MA; Mesgouez-Nebout N
    Cancer Radiother; 2013 Feb; 17(1):10-20. PubMed ID: 23270680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary mucoepidermoid carcinoma of the esophagus.
    Chen S; Chen Y; Yang J; Yang W; Weng H; Li H; Liu D
    J Thorac Oncol; 2011 Aug; 6(8):1426-31. PubMed ID: 21587086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
    Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy in the multimodality management of esophageal cancer.
    Encheva E; Kolev N; Tonev A; Ignatov V; Shterev S; Petrov D; Zlatarov A; Koleva I; Chaushev B; Kirilova T; Ivanov K
    Khirurgiia (Sofiia); 2014; (3):12-9. PubMed ID: 25799618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
    Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
    Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.